Cargando…
Pansclerotic Morphea Following COVID-19: A Case Report and Review of Literature on Rheumatologic and Non-rheumatologic Dermatologic Immune-Mediated Disorders Induced by SARS-CoV-2
While mucocutaneous manifestations of COVID-19 have been frequently reported and added to our knowledge every day during the pandemic, another issue is the COVID-related diseases that can present as intensified lesions of underlying diseases, a new disease, or changes in the behavior of an old lesio...
Autores principales: | Lotfi, Zahra, Haghighi, Anousheh, Akbarzadehpasha, Amirhossein, Mozafarpoor, Samaneh, Goodarzi, Azadeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564069/ https://www.ncbi.nlm.nih.gov/pubmed/34746174 http://dx.doi.org/10.3389/fmed.2021.728411 |
Ejemplares similares
-
Adult-Onset Unilateral Disabling Pansclerotic Morphea
por: Singh, Adarshlata, et al.
Publicado: (2014) -
Disabling Pansclerotic Morphea of Childhood with Extracutaneous Manifestations
por: Kura, Mahendra M, et al.
Publicado: (2013) -
Pansclerotic morphea: A male child with hemiatrophy of lower limb
por: Dasgupta, Malay K., et al.
Publicado: (2014) -
Disabling pansclerotic morphea of childhood – unusual case and management challenges
por: Ana-Maria, Forsea, et al.
Publicado: (2008) -
Hyaluronidase injections for treatment of symptomatic pansclerotic morphea-induced microstomia
por: Abbas, Laila F., et al.
Publicado: (2019)